医学
肝病学
嗜酸性食管炎
内科学
布地奈德
胃肠病学
肾病科
痹症科
炎症性肠病
重症监护医学
皮质类固醇
疾病
作者
Xavier Verhelst,Martine De Vos,Hans Van Vlierberghe
出处
期刊:Journal of Translational Internal Medicine
[De Gruyter]
日期:2014-06-01
卷期号:2 (2): 53-58
被引量:2
标识
DOI:10.4103/2224-4018.135601
摘要
Abstract Although they have been introduced a long time ago, corticosteroids are still extensively used for the treatment of several gastroenterological and hepatological diseases. The goal of this review is to provide an overview of current indications for the optimal use of corticosteroids in this field. For a growing number of indications, budesonide can be an interesting alternative for systemic corticosteroids due to its rapid first-pass hepatic metabolism. Furthermore, topical corticosteroids are increasingly used, e.g., for the treatment of eosinophilic esophagitis and selected patients with inflammatory bowel disease. We conclude that corticosteroids remain of great importance in gastroenterology and hepatology, but the balance between benefit and side-effects use should be evaluated cautiously.”
科研通智能强力驱动
Strongly Powered by AbleSci AI